Vaxcyte Cash Flow Statement (2019-2026) | PCVX

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-23.64M-120.32M-29.75M-118.57M-113.54M-131.53M-79.94M-207.78M-316.10M-343.44M-179.11M-455.93M-133.95M-115.48M-117.31M-150.94M-316.12M-331.15M-378.18M-322.95M
Share-based Compensation (Quarter)
0.98M1.91M2.43M4.10M3.55M3.97M-15.78M9.65M0.02M24.30M-31.54M17.63M21.56M-25.98M71.61M5.29M0.72M96.84M-91.86M9.29M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
0.06M0.16M-0.01M
Cash from Operations (Quarter)
-28.68M-28.41M-51.09M-27.70M-39.13M-38.55M-65.22M-47.69M-62.74M-57.55M-128.81M-159.12M-121.39M-60.71M-111.40M-166.27M-121.17M-143.31M-224.83M-280.62M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.33M-0.43M-0.50M-0.32M-0.14M0.24M1.18M5.99M11.84M14.57M2.37M10.99M9.93M6.10M11.68M4.91M4.49M2.26M2.76M3.11M
Amortization of Deferred Charges (Quarter)
0.38M0.35M0.75M1.79M1.56M1.67M1.60M1.63M1.65M1.67M2.06M2.09M2.13M2.70M1.92M1.92M2.11M2.13M2.30M2.91M
Depreciation & Amortization (CF) (Quarter)
0.48M0.51M0.46M0.58M0.61M0.68M0.96M0.71M0.75M0.81M0.89M1.00M1.35M1.79M2.86M2.96M2.88M3.06M7.50M2.95M
Change in Working Capital
Change in Account Payables (Quarter)
1.92M1.50M-18.07M-1.93M2.71M-1.35M3.47M1.79M2.26M0.69M6.48M5.67M-10.71M8.31M31.31M-29.16M9.53M17.88M21.67M-0.27M
Change in Accured Expenses (Quarter)
2.38M-1.73M2.84M-0.74M-0.66M1.39M7.17M3.04M0.20M2.51M4.13M-7.97M3.38M5.77M8.34M-14.42M13.02M-2.53M6.23M-15.02M
Other Working Capital Changes (Quarter)
-1.80M-1.84M2.38M43.15M16.00M-1.36M-1.40M33.14M-1.28M
Investing Activities
Capital Expenditures (Quarter)
1.92M-3.18M6.28M0.66M3.19M0.84M-4.59M5.61M-1.45M-3.73M15.63M5.68M-0.40M13.13M4.02M5.42M1.81M-1.67M1.97M2.11M
Sales of Property, Plant and Equipment (Quarter)
0.03M0.01M
Change in Acquisitions & Divestments (Quarter)
40.94M42.50M3.50M7.00M158.19M1.13M1.29M6.37M603.09M6.38M9.55M853.76M-802.73M438.49M394.48M350.20M347.97M340.63M
Cash from Investing Activities (Quarter)
-20.53M-18.47M0.08M49.67M26.16M34.71M-35.95M-448.10M-333.56M22.28M-13.93M-451.07M-80.41M-917.02M-557.17M123.32M77.74M121.17M115.12M-233.41M
Financing Activities
Other financing activities (Quarter)
0.47M0.49M1.57M0.28M0.27M5.38M0.50M0.52M2.52M4.11M5.02M4.40M11.74M5.98M6.05M3.23M0.31M3.42M9.03M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
4.21M1.10M5.30M7.16M1.56M4.69M7.72M9.15M6.49M4.33M4.65M
Net Equity Issued and Repurchased (Quarter)
7.11M6.79M3.12M49.00M43.12M2.06M41.79M49.00M-0.05M106.51M89.46M-0.03M264.20M
Misc.
Cash from Financing Activities (Quarter)
0.96M7.60M8.75M111.02M49.88M44.02M656.63M41.56M546.97M48.55M2.73M818.20M110.37M1,515.04M4.91M0.76M2.52M-3.67M2.41M601.58M
Exchange Rate Effect (Quarter)
0.31M0.33M-0.80M-0.23M-0.48M0.05M0.80M0.02M-0.08M1.05M-7.68M6.06M-1.41M-5.58M1.35M1.17M0.80M0.29M0.18M-0.66M
Change in Cash (Quarter)
-47.94M-38.95M-43.06M132.76M36.43M40.23M556.26M-454.21M150.58M14.33M-147.68M214.06M-92.84M531.73M-662.31M-41.03M-40.11M-25.52M-107.12M86.88M
Free Cash Flow (Quarter)
-30.60M-25.23M-57.38M-28.37M-42.32M-39.39M-60.63M-53.30M-61.30M-53.82M-144.44M-164.80M-121.00M-73.83M-115.42M-171.70M-122.98M-141.64M-226.80M-282.73M
Net Cash Flow (Quarter)
-48.25M-39.28M-42.26M132.98M36.92M40.17M555.46M-454.23M150.66M13.28M-140.00M208.00M-91.43M537.31M-663.66M-42.20M-40.91M-25.81M-107.30M87.55M